These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28488704)

  • 1. Targeting curcumin to specific tumour cell environments: the influence of ancillary ligands.
    Glenister A; Chen CKJ; Tondl EM; Paterson D; Hambley TW; Renfrew AK
    Metallomics; 2017 Jun; 9(6):699-705. PubMed ID: 28488704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cobalt(III) Chaperone Complexes of Curcumin: Photoreduction, Cellular Accumulation and Light-Selective Toxicity towards Tumour Cells.
    Renfrew AK; Bryce NS; Hambley T
    Chemistry; 2015 Oct; 21(43):15224-34. PubMed ID: 26471438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
    Yamamoto N; Renfrew AK; Kim BJ; Bryce NS; Hambley TW
    J Med Chem; 2012 Dec; 55(24):11013-21. PubMed ID: 23199008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
    Banerjee S; Chakravarty AR
    Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the ancillary ligand on the potential of cobalt(iii) complexes to act as chaperones for hydroxamic acid-based drugs.
    Green BP; Renfrew AK; Glenister A; Turner P; Hambley TW
    Dalton Trans; 2017 Nov; 46(45):15897-15907. PubMed ID: 29116280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.
    O'Neill ES; Kaur A; Bishop DP; Shishmarev D; Kuchel PW; Grieve SM; Figtree GA; Renfrew AK; Bonnitcha PD; New EJ
    Inorg Chem; 2017 Aug; 56(16):9860-9868. PubMed ID: 28766939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cobalt complexes as anticancer agents.
    Munteanu CR; Suntharalingam K
    Dalton Trans; 2015 Aug; 44(31):13796-808. PubMed ID: 26148776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photorelease and Cellular Delivery of Mitocurcumin from Its Cytotoxic Cobalt(III) Complex in Visible Light.
    Garai A; Pant I; Banerjee S; Banik B; Kondaiah P; Chakravarty AR
    Inorg Chem; 2016 Jun; 55(12):6027-35. PubMed ID: 27244480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
    Bonnitcha PD; Kim BJ; Hocking RK; Clegg JK; Turner P; Neville SM; Hambley TW
    Dalton Trans; 2012 Oct; 41(37):11293-304. PubMed ID: 22885674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs.
    Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC
    Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the effect of gallium curcumin and gallium diacetylcurcumin complexes on the structure, function and oxidative stability of the peroxidase enzyme and their anticancer and antibacterial activities.
    Jahangoshaei P; Hassani L; Mohammadi F; Hamidi A; Mohammadi K
    J Biol Inorg Chem; 2015 Oct; 20(7):1135-46. PubMed ID: 26369539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warburg Effect Targeting Co(III) Cytotoxin Chaperone Complexes.
    Glenister A; Chen CKJ; Paterson DJ; Renfrew AK; Simone MI; Hambley TW
    J Med Chem; 2021 Mar; 64(5):2678-2690. PubMed ID: 33621096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cobalt(II) complexes with dipyridylamine and salicylaldehydes on cultured tumor and non-tumor cells: synthesis, crystal structure investigations and biological activity.
    Lalia-Kantouri M; Gdaniec M; Choli-Papadopoulou T; Badounas A; Papadopoulos CD; Czapik A; Geromichalos GD; Sahpazidou D; Tsitouroudi F
    J Inorg Biochem; 2012 Dec; 117():25-34. PubMed ID: 23078772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of curcumin-lactoferrin conjugated nanostructures for cancerous cells.
    Chaharband F; Kamalinia G; Atyabi F; Mortazavi SA; Mirzaie ZH; Dinarvand R
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):626-636. PubMed ID: 28622061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum to: Investigating the effect of gallium curcumin and gallium diacetylcurcumin complexes on the structure, function and oxidative stability of the peroxidase enzyme and their anticancer and antibacterial activities.
    Jahangoshaei P; Hassani L; Mohammadi F; Hamidi A; Mohammadi K
    J Biol Inorg Chem; 2015 Dec; 20(8):1343. PubMed ID: 26588932
    [No Abstract]   [Full Text] [Related]  

  • 16. Water-Soluble Pd
    Bhat IA; Jain R; Siddiqui MM; Saini DK; Mukherjee PS
    Inorg Chem; 2017 May; 56(9):5352-5360. PubMed ID: 28394128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterodinuclear ruthenium(II)-cobalt(III) complexes as models for a new approach to selective cancer treatment.
    Downward AM; Jane RT; Polson MI; Moore EG; Hartshorn RM
    Dalton Trans; 2012 Dec; 41(47):14425-32. PubMed ID: 23042609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-Conjugated Gold Clusters for Bioimaging and Anticancer Applications.
    Govindaraju S; Rengaraj A; Arivazhagan R; Huh YS; Yun K
    Bioconjug Chem; 2018 Feb; 29(2):363-370. PubMed ID: 29323877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A safe and efficacious Pt(ii) anticancer prodrug: design, synthesis, in vitro efficacy, the role of carrier ligands and in vivo tumour growth inhibition.
    Dutta PK; Sharma R; Kumari S; Dubey RD; Sarkar S; Paulraj J; Vijaykumar G; Pandey M; Sravanti L; Samarla M; Das HS; Yashpal ; B H; Goyal R; Gupta N; Mandal SK; Sengupta A; Sarkar A
    Chem Commun (Camb); 2019 Feb; 55(12):1718-1721. PubMed ID: 30623966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.
    Mathuber M; Schueffl H; Dömötör O; Karnthaler C; Enyedy ÉA; Heffeter P; Keppler BK; Kowol CR
    Inorg Chem; 2020 Dec; 59(23):17794-17810. PubMed ID: 33222438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.